Stroke and bleeding risk in atrial fibrillation. - Wikidata - awgldk - TriplyDB

Stroke and bleeding risk in atrial fibrillation.

Stroke and bleeding risk in atrial fibrillation.

http://www.wikidata.org/entity/Q34269633

about

New Oral Anticoagulants in Nonvalvular Atrial Fibrillation Clinical application of a new warfarin-dosing regimen based on the CYP2C9 and VKORC1 genotypes in atrial fibrillation patients Bridging the gender gap in atrial fibrillation.Increased Risk of Atrial Fibrillation and Thromboembolism in Patients with Severe Psoriasis: a Nationwide Population-based Study.Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?Management of Atrial Fibrillation in Elderly Adults.No Evidence for an Association Between Renal Function and Serious Bleeding Events in Patients Treated With Coumarins: A Population-Based Study.Left Atrial Strain Predicts Pro-Thrombotic State in Patients with Non-Valvular Atrial Fibrillation.Oral Anticoagulants for Atrial Fibrillation Patients with Active Cancer.

P2860

Q28066141-A1A78E88-D86F-4B78-AE38-396C283EA8EB Q36741112-A722D96C-E505-487E-AFAA-A79BCA6EECB3 Q38317687-2AA6EC0D-794D-40A3-82D9-73FD89DBFF06 Q38601541-83E5E556-C1FA-486C-94F9-784A8D076349 Q38728028-70327888-C5EB-4364-B1DB-BA3F451C5797 Q39026788-3AA299D0-0B34-4AE9-8608-6EAB8C8D1D1C Q47849138-33E7F5D1-024F-4C6F-A9DC-D135641ECB71 Q50309044-FD6A9554-706B-43F1-A8A7-FE2A24F1401A Q55025623-59E12981-9B55-41F2-BDCD-BB23376BAE2A

P2860

Stroke and bleeding risk in atrial fibrillation.

http://www.wikidata.org/entity/Q34269633

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Stroke and bleeding risk in atrial fibrillation.

@ast

Stroke and bleeding risk in atrial fibrillation.

@en

Stroke and bleeding risk in atrial fibrillation.

@nl

type

label

Stroke and bleeding risk in atrial fibrillation.

@ast

Stroke and bleeding risk in atrial fibrillation.

@en

Stroke and bleeding risk in atrial fibrillation.

@nl

prefLabel

Stroke and bleeding risk in atrial fibrillation.

@ast

Stroke and bleeding risk in atrial fibrillation.

@en

Stroke and bleeding risk in atrial fibrillation.

@nl

P1433

Q34269633-35C39B7E-2BF6-4C91-A881-AFD39D75D3A2

P1476

Q34269633-1CB6DFDC-F552-4C7E-8796-4031C5035350

P2093

Q34269633-00C9EA47-BACD-4167-8A80-BEC9910C12BA

Q34269633-0D071F86-5762-4779-A75B-46C2856C5A91

Q34269633-C65CDC84-6673-4CE6-876C-F72F61E6143B

P2860

Q34269633-0D39E5C0-ACED-4ACE-937E-3427D8C60729

Q34269633-10154480-2138-4311-B222-D4D44A331748

Q34269633-14BE3124-80F2-458A-AE30-571E7C30C52D

Q34269633-1711EB50-AA6C-4AA0-878D-108A38478851

Q34269633-1D188EEF-4A47-4E16-825C-0DECDE88C88C

Q34269633-244B6AA5-E209-4BD1-BCFE-675A14EC1BEC

Q34269633-28CB3CF7-9F0C-4073-A175-EEE028ACA51D

Q34269633-2A15EEE5-F710-4F2E-BC0F-01D21B09F94A

Q34269633-35006166-9125-4BE1-A9D0-714B355779A0

Q34269633-392CD951-2528-4BEE-9F96-4E5036B47FE0

P304

Q34269633-80B79C3F-4F13-4839-8BB6-74ACA64A64A4

P31

Q34269633-3FAF778C-B54B-4B07-A8D4-92D9813D0F2B

P356

Q34269633-52C36E71-C393-4DB6-AF08-E1E0A7CD66F5

P433

Q34269633-D4F0E5FC-7C9F-4113-9C5D-607EFE7D5495

P478

Q34269633-DBE4EBCE-FB25-4A93-9F52-C44D06C49F6F

P577

Q34269633-822EE872-1D4E-4A98-833F-C90131E29320

P5875

Q34269633-3CA22CC9-3813-44CF-B35C-FC330BAA40FB

P698

Q34269633-E787F77D-F810-403F-B4BB-B6B85B605EBE

P921

Q34269633-773A58B6-883C-4949-8047-29EDFEE0FD70

P932

Q34269633-E326572E-E351-4E8A-BD08-BE6F491FE6C7

P356

KCJ.2014.44.5.281

P1433

Korean circulation journal

P1476

Stroke and bleeding risk in atrial fibrillation.

@en

P2093

Deirdre Lane

http://www.w3.org/2001/XMLSchema#string

Gregory Yh Lip

http://www.w3.org/2001/XMLSchema#string

Keitaro Senoo

http://www.w3.org/2001/XMLSchema#string

P2860

Independent predictors of stroke in patients with atrial fibrillation: a systematic review

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation

Dabigatran versus warfarin in patients with atrial fibrillation

Validation of Clinical Classification Schemes for Predicting Stroke

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Apixaban versus warfarin in patients with atrial fibrillation

Edoxaban versus warfarin in patients with atrial fibrillation

P304

281-290

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4070/KCJ.2014.44.5.281

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266401554

http://www.w3.org/2001/XMLSchema#string

P698

25278980

http://www.w3.org/2001/XMLSchema#string

P921

atrial fibrillation

P932

4180604

http://www.w3.org/2001/XMLSchema#string